NZ631279A - Method for treatment of labor arrest - Google Patents

Method for treatment of labor arrest

Info

Publication number
NZ631279A
NZ631279A NZ631279A NZ63127913A NZ631279A NZ 631279 A NZ631279 A NZ 631279A NZ 631279 A NZ631279 A NZ 631279A NZ 63127913 A NZ63127913 A NZ 63127913A NZ 631279 A NZ631279 A NZ 631279A
Authority
NZ
New Zealand
Prior art keywords
labour
activity
treatment
antifactor
less
Prior art date
Application number
NZ631279A
Other languages
English (en)
Inventor
Gunvor Ekman-Ordeberg
Anders Malmström
Original Assignee
Dilafor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dilafor Ab filed Critical Dilafor Ab
Publication of NZ631279A publication Critical patent/NZ631279A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NZ631279A 2012-03-26 2013-03-25 Method for treatment of labor arrest NZ631279A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261615400P 2012-03-26 2012-03-26
PCT/SE2013/050333 WO2013147690A1 (en) 2012-03-26 2013-03-25 Method for treatment of labor arrest

Publications (1)

Publication Number Publication Date
NZ631279A true NZ631279A (en) 2016-06-24

Family

ID=49260784

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ631279A NZ631279A (en) 2012-03-26 2013-03-25 Method for treatment of labor arrest

Country Status (15)

Country Link
US (1) US20150057226A1 (enExample)
EP (1) EP2830634A4 (enExample)
JP (1) JP2015514705A (enExample)
CN (1) CN104244957B (enExample)
AU (1) AU2013240598A1 (enExample)
CA (1) CA2868479A1 (enExample)
HK (1) HK1203370A1 (enExample)
MX (1) MX2014011451A (enExample)
MY (1) MY185108A (enExample)
NZ (1) NZ631279A (enExample)
RU (1) RU2014143008A (enExample)
SG (1) SG11201406118QA (enExample)
UA (1) UA117907C2 (enExample)
WO (1) WO2013147690A1 (enExample)
ZA (1) ZA201406567B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
SMT201800143T1 (it) 2011-12-19 2018-05-02 Dilafor Ab Glicosaminoglicani non anticoagulanti comprendenti un'unita ripetitiva di disaccaridi e loro uso medico
SG10201607872PA (en) 2012-03-26 2016-11-29 Santen Pharmaceutical Co Ltd Ophthalmic solution comprising diquafosol
CA2868403A1 (en) * 2012-05-08 2013-11-14 Dilafor Ab Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent
KR20220142508A (ko) 2020-02-17 2022-10-21 딜라포 아베 자간전증 치료용 타폭시파린
CA3255831A1 (en) 2022-05-03 2023-11-09 Dilafor Ab NEW MEDICAL USE OF TAFOXIPARIN
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin
AU2024213271A1 (en) * 2023-02-01 2025-07-17 Materna Medical, Inc. Methods and apparatus for preventing vaginal lacerations during childbirth

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000065837A (ja) * 1998-08-24 2000-03-03 Seikagaku Kogyo Co Ltd グリコサミノグリカン又はグリコサミノグリカン結合性分子の測定方法及びその測定用キット
JP2000309544A (ja) * 1999-02-25 2000-11-07 Seikagaku Kogyo Co Ltd 早産または流産防止剤および子宮頚管熟化抑制剤ならびにヒアルロニダーゼの阻害剤
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
US8445436B2 (en) * 2007-12-03 2013-05-21 Florida State University Research Foundation, Inc. Oxytocin and melatonin compositions and associated methods for inducing labor
SMT201800143T1 (it) * 2011-12-19 2018-05-02 Dilafor Ab Glicosaminoglicani non anticoagulanti comprendenti un'unita ripetitiva di disaccaridi e loro uso medico

Also Published As

Publication number Publication date
AU2013240598A1 (en) 2014-10-02
CA2868479A1 (en) 2013-10-03
HK1203370A1 (en) 2015-10-30
SG11201406118QA (en) 2014-11-27
WO2013147690A1 (en) 2013-10-03
MX2014011451A (es) 2014-11-10
EP2830634A1 (en) 2015-02-04
JP2015514705A (ja) 2015-05-21
MY185108A (en) 2021-04-30
CN104244957A (zh) 2014-12-24
CN104244957B (zh) 2017-11-17
ZA201406567B (en) 2017-06-28
US20150057226A1 (en) 2015-02-26
RU2014143008A (ru) 2016-05-20
UA117907C2 (uk) 2018-10-25
EP2830634A4 (en) 2016-01-20

Similar Documents

Publication Publication Date Title
NZ631279A (en) Method for treatment of labor arrest
TN2014000236A1 (en) Use of chemically modified heparin derivates in sickle cell disease
MY174018A (en) Heterocyclic derivates
PH12015502042A1 (en) Use of linagliptin in cardio-and renoprotective antidiabetic therapy
IN2015DN01156A (enExample)
MY193818A (en) Triazole agonists of the apj receptor
MX2015014582A (es) Agentes para regulacion hacia abajo de la actividad y/o cantidad de bcl-xl y/o bcl-w.
ES2529143R1 (es) Combinacion de al menos dos agentes antivirales de accion directa, ribavirina pero no interferon para uso de tratamiento del vhc
MY199027A (en) Method for treating or preventing ophthalmological conditions
PH12014502577A1 (en) Compositions comprising an anti-pdgf aptamer and a vegf antagonist
EA201591543A1 (ru) Комбинированные терапии для лечения рака с применением микрорнк и ингибиторов egfr-tki
WO2014144606A3 (en) Methods of treating muscular dystrophy
MX351104B (es) Nuevos glucosaminoglucanos con baja actividad anticoagulante.
MX2014010940A (es) El uso de antitrombina en el tratamiento de preeclampsia.
EA201591424A1 (ru) Способы лечения дефицита железа растворимым пирофосфатом железа
PH12016500465A1 (en) Deoxynojirimycin derivatives and methods of their using
MY175743A (en) Combination treatment comprising sulphated glycosaminoglycans for inducing labor
WO2014165713A3 (en) Treatment of inflammatory conditions by modulation of hyaluronan and hyaluronidase activity
IN2013MU03773A (enExample)
MY182591A (en) Compositions for use in treating eye disorders using dipyridamole
PH12014500577A1 (en) Sulfonic acid salts of heterocyclylamide-substituted imidazoles
MX2014013449A (es) Tratamiento de la hemorragia postparto (pph) con heparina modificada quimicamente o sulfato de heparan y un agente uterotonico.
MX2016007795A (es) Uso de antagonistas del par-1 para prevenir y/o tratar condiciones patologicas funcionales pelviperineales.
PH12014501044B1 (en) Methods for improved wound closure employing olivamine and human umbilical vien endothelial cells
PH12016501127A1 (en) Adenosine a1 agonists as medicaments against renal diseases

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 MAR 2018 BY CPA GLOBAL(PATRAFEE)

Effective date: 20170321

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 MAR 2019 BY CPA GLOBAL(PATRAFEE) AB

Effective date: 20180307

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 MAR 2020 BY CPA GLOBAL(PATRAFEE) AB

Effective date: 20190307

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 MAR 2021 BY CPA GLOBAL (PATRAFEE) AB

Effective date: 20200312

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 MAR 2022 BY CAMILLA WELLIN / CPA GLOBAL

Effective date: 20210223

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 MAR 2023 BY CAMILLA WELLIN / CPA GLOBAL CLARIVATE

Effective date: 20220312

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 MAR 2024 BY CPA GLOBAL (PATRAFEE) AB

Effective date: 20230302

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 MAR 2025 BY CPA GLOBAL (PATRAFEE) AB

Effective date: 20240305

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 MAR 2026 BY CPA GLOBAL (PATRAFEE) AB

Effective date: 20250307